These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34941395)

  • 1. Enabling commercial success of industrial biotechnology.
    Biggs BW; Alper HS; Pfleger BF; Tyo KEJ; Santos CNS; Ajikumar PK; Stephanopoulos G
    Science; 2021 Dec; 374(6575):1563-1565. PubMed ID: 34941395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invention and commercialization in optical bioimaging.
    Farkas DL
    Nat Biotechnol; 2003 Nov; 21(11):1269-71. PubMed ID: 14595349
    [No Abstract]   [Full Text] [Related]  

  • 3. Enabling the Advanced Bioeconomy through Public Policy Supporting Biofoundries and Engineering Biology.
    Kitney R; Adeogun M; Fujishima Y; Goñi-Moreno Á; Johnson R; Maxon M; Steedman S; Ward S; Winickoff D; Philp J
    Trends Biotechnol; 2019 Sep; 37(9):917-920. PubMed ID: 31036350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine: real commercial potential or just hype?
    Webster TJ
    Int J Nanomedicine; 2006; 1(4):373-4. PubMed ID: 17722271
    [No Abstract]   [Full Text] [Related]  

  • 5. Australia's bio-regulatory framework: leading the way for stem cell research.
    Hill H
    J Biolaw Bus; 2004; 7(2):61-4. PubMed ID: 15460561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomania meets the bottom line.
    Malakoff D; Service RF
    Science; 2001 Feb; 291(5507):1193-203. PubMed ID: 11233434
    [No Abstract]   [Full Text] [Related]  

  • 7. Public biotechnology 2002--the numbers.
    Lähteenmäki R; DeFrancesco L
    Nat Biotechnol; 2003 Jun; 21(6):607-12. PubMed ID: 12776143
    [No Abstract]   [Full Text] [Related]  

  • 8. The biotechnology bubble machine.
    Rasnick D
    Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
    [No Abstract]   [Full Text] [Related]  

  • 9. European biotechnology firms approve of stock market mergers.
    Michael A
    Nat Biotechnol; 1998 Dec; 16(13):1301. PubMed ID: 9853595
    [No Abstract]   [Full Text] [Related]  

  • 10. Clean technology: industry and environment, a viable partnership?
    Bull AT
    Biologist (London); 2000 Apr; 47(2):61-4. PubMed ID: 11190229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White biotechnology: ready to partner and invest in.
    Kircher M
    Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocatalysts: application and engineering for industrial purposes.
    Jemli S; Ayadi-Zouari D; Hlima HB; Bejar S
    Crit Rev Biotechnol; 2016; 36(2):246-58. PubMed ID: 25373789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy.
    Aguilar A; Magnien E; Thomas D
    N Biotechnol; 2013 Jun; 30(5):410-25. PubMed ID: 23195849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Biotech in the financial crisis.
    Jungbauer A
    Biotechnol J; 2009 Aug; 4(8):1095. PubMed ID: 19685457
    [No Abstract]   [Full Text] [Related]  

  • 15. Rainbow biotech--South Africa's emerging sector.
    Louët S
    Nat Biotechnol; 2006 Nov; 24(11):1313-6. PubMed ID: 17093464
    [No Abstract]   [Full Text] [Related]  

  • 16. The hermit crab solution.
    Silverman E
    Nat Biotechnol; 2006 Mar; 24(3):245-7. PubMed ID: 16680810
    [No Abstract]   [Full Text] [Related]  

  • 17. Public biotech 99: the numbers.
    Lähteenmäki R; Hodgson J
    Nat Biotechnol; 2000 May; 18(5):499-503. PubMed ID: 10802615
    [No Abstract]   [Full Text] [Related]  

  • 18. From the first drop to the first truckload: commercialization of microbial processes for renewable chemicals.
    Van Dien S
    Curr Opin Biotechnol; 2013 Dec; 24(6):1061-8. PubMed ID: 23537815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Business Models in Funding the Biotech Industry: Global Trends and Challenges for Cuban Biotechnology.
    Blanco-García E
    MEDICC Rev; 2020 Jan; 22(1):11-16. PubMed ID: 32327617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Realizing potential: the state of Asian bioentrepreneurship.
    Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.